SBIR/STTR Research Award
PHASE I - FASTING MIMICKING DIETS AND IMMUNOSENESCENCE 09/22/2014 - 06/21/2015. CAN: 14-8469754
Award amount
$196,647Program and phase
SBIR · Phase IAward year
2014Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- L-Nutra Inc.
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- NIA
Research abstract
Intermittent or Periodic Fasting have been reported to promote lifespan extension and provide a range of protective effects, including neural stem cell generation in the nervous system and protection against chemotherapy side effects or cancer progression.USC researchers have described the role of short-term fasting in the protection of normal but not cancer cells from chemotherapy. New results by L-Nutra and the Longo laboratory suggest that short-term fasting may also enhance immune function. Because short-term fasting cycles can exacerbate pre-existing malnourishment or low weight/BMI, are difficult for most people to follow, and are very unlikely to be recommended by physicians, L-Nutra is formulating fasting mimicking and enhancing diets(FMEDs) to be adopted periodically that are highly nutritive, but provide the beneficial effects of fasting. PUBLIC HEALTH RELEVANCE
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Evaluate the Safety, Tolerability, and Immunogenicity of Adjuvanted Preventive Dual Aβ/tau Vaccine, Duvax in Healthy Volunteers
- A Drug Discovery Platform to Prioritize Development of Natural Product Neuromodulators for Treating Cognitive Impairment
- VR-CARES: Feasibility of Virtual Reality for Caregiver Assembly, Relief, Empowerment, and Support to improve social connection, health, and at-home dementia care
- Developing an Integrated Brain State Monitor for Personalized Anesthesia Decision Support: Preventing Postoperative Delirium in Elderly and Patients At Risk for Alzheimer's or Related Dementias
- Lead Optimization of a Therapeutic Candidate for Alzheimer’s Disease